AivoCode, Inc.
PrivateLast Round
Grant
Apr 6, 2026
Total Funding Raised
$5.23M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
AivoCode, Inc. operates in Enterprise Software and is based in San Diego, California. Its latest recorded funding round was a Grant round in April 2026.
AivoCode, Inc. is a biotechnology company that develops novel therapeutic candidates and platform technologies for the treatment of neurological and neurodegenerative diseases such as traumatic brain injury and Alzheimer's disease.
Sector
Enterprise Software
Verticals
Workflow Automation, Project Management
Business Model
B2G
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AivoCode, Inc. Comparables
Compare AivoCode, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Gryphon Bio | 32% |
For institutional investors. Book with your work email.
AivoCode, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 6, 2026 | ||||
| Seed | Jun 1, 2025 | ||||
| Grant | Sep 9, 2021 | ||||
| Grant | Sep 1, 2019 | ||||
| Grant | Apr 1, 2017 | ||||
Grant | Jun 1, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
AivoCode, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 2, 2026
Open roles increased to 3, representing 75% of headcount.
- Aug 10, 2026
Open roles increased from 0 to 1, representing 33% of headcount.
For institutional investors. Book with your work email.
AivoCode, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AivoCode, Inc.'s valuation, stock price, and market status.
Is AivoCode, Inc. a public or private company?
AivoCode, Inc. is a private company.
What is the current stock price of AivoCode, Inc.?
AivoCode, Inc. is a private company, so its shares have no public market price. Caplight tracks AivoCode, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AivoCode, Inc. worth (valuation)?
Valuation information for AivoCode, Inc. is not publicly available.
Can I buy AivoCode, Inc. stock?
AivoCode, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AivoCode, Inc.'s last funding round?
AivoCode, Inc.'s most recent funding round was Grant on April 6, 2026.
Who are the main investors in AivoCode, Inc.?
Key investors in AivoCode, Inc. include NIH RADx, National Science Foundation.
Will AivoCode, Inc. IPO soon?
No public IPO plans have been announced for AivoCode, Inc..
How can I track AivoCode, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in AivoCode, Inc.'s shares on secondary markets.